Caminati, M.; Marcon, A.; Guarnieri, G.; Miotti, J.; Bagnasco, D.; Carpagnano, G.E.; Pelaia, G.; Vaia, R.; Maule, M.; Vianello, A.;
et al. Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective. J. Clin. Med. 2023, 12, 1836.
https://doi.org/10.3390/jcm12051836
AMA Style
Caminati M, Marcon A, Guarnieri G, Miotti J, Bagnasco D, Carpagnano GE, Pelaia G, Vaia R, Maule M, Vianello A,
et al. Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective. Journal of Clinical Medicine. 2023; 12(5):1836.
https://doi.org/10.3390/jcm12051836
Chicago/Turabian Style
Caminati, Marco, Alessandro Marcon, Gabriella Guarnieri, Jessica Miotti, Diego Bagnasco, Giovanna Elisiana Carpagnano, Girolamo Pelaia, Rachele Vaia, Matteo Maule, Andrea Vianello,
and et al. 2023. "Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective" Journal of Clinical Medicine 12, no. 5: 1836.
https://doi.org/10.3390/jcm12051836
APA Style
Caminati, M., Marcon, A., Guarnieri, G., Miotti, J., Bagnasco, D., Carpagnano, G. E., Pelaia, G., Vaia, R., Maule, M., Vianello, A., & Senna, G.
(2023). Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective. Journal of Clinical Medicine, 12(5), 1836.
https://doi.org/10.3390/jcm12051836
